Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.33 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16320524 | 0.81 | AXL (0.36) | MAP3K11CYP3A4CYP2C19BRAFCAMKK2 | |
| SCHEMBL26018150 | 0.81 | BRAF (0.40) | MAP3K11CYP3A4CYP2C9MAPK8MAPK9 | |
| SCHEMBL1772956 | 0.81 | MAP3K11 (0.39) | MAP3K11CYP3A4MAPK8MAPK9MAPK10 | |
| SCHEMBL7921128 | 0.77 | MET (0.46) | CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL7965037 | 0.75 | CYP3A4 (0.44) | CYP3A4CYP2C19CYP2C9KIT | |
| SCHEMBL1772835 | 0.74 | ALDH1A1 (0.43) | MAP3K11BRAF | |
| SCHEMBL13199598 | 0.74 | CYP3A4 (0.44) | CYP3A4CYP2C19CYP2C9BRAFKIT | |
| SCHEMBL31228005 | 0.74 | BRD4 (0.54) | CYP3A4CYP2C19CYP2C9MAPK8KIT | |
| SCHEMBL21902710 | 0.74 | CYP2C19 (0.40) | MAP3K11CYP3A4CYP2C19CYP2C9BRAF | |
| SCHEMBL15154998 | 0.74 | GSK3B (0.56) | MAP3K11CYP3A4CYP2C19CYP2C9NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131122-A1 | FUSED RING-SUBSTITUTED SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2023-07-13 | — | — | WO | disclosed |